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Řěșěǻřčħįňģ Șčħįżǿpħřěňįǻ
New research from a team of psychologists including University of Dayton assistant professor
Julie Walsh-Messinger has uncovered key genes linked to different symptoms of schizophrenia
— a discovery that could lead to better, more precise treatments for individuals.
The study “represents a much-needed step forward” by identifying four previously
unknown genetic diseases within the umbrella diagnosis of schizophrenia. Walsh-
Messinger worked with researchers at New York University Langone Medical Center to
evaluate patients, and their findings are published in the current issue of the journal
EBioMedicine.
“People have been studying schizophrenia for over 100 years now, trying to figure out
what causes it and how to treat it effectively,” Walsh-Messinger said. “These findings are
incredibly exciting because we are actually able to identify four different pathways to the
disorder that we call schizophrenia.
“It’s a heterogeneous disorder, which means one person with schizophrenia can look very different from another person
with schizophrenia. And, although it only affects a very small subset of the population — about 1 percent — it causes a lot
of social and occupational  dysfunction and makes it very challenging for these individuals to experience fulfillment in
their lives and be productive members of society.”
The authors say their research is important because “patients may respond well to one medication but not another” and
doctors “currently have little to guide their decisions besides trial and error.”
Walsh-Messinger said, for instance, the team found a SLC39A13 mutation related to certain symptoms. The gene is a zinc
transporter, so zinc augmentation could be a good starting point for treatment. However, that treatment might not be
effective for someone without that mutation. More information on the genes is available from NYU.
Walsh-Messinger said the study is ongoing, and will need to be expanded to a larger population.
“There’s still a lot to be discovered,” she said. “But this gives us a good starting point for how to approach treatment.”
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For more information, contact Meagan Pant, assistant director of media relations, at 937-229-3256 or
mpant1@udayton.edu.
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Briefly Speaking
Black History Month Mass, immigration, career fair, Engineering Week, LSAT workshop, Catholic art, business leadership
among upcoming events.
READ MORE 
On The Academic Minute
Assistant sociology professor Ruth Thompson-Miller was featured on the popular radio program, The Academic Minute,
explaining the lasting effects of Jim Crow laws.
READ MORE 
Colleges That Pay You Back
Julie Walsh-Messinger
Phenotypically distinct subtypes of psychosis accompany novel or rare variants in four
different signaling genes
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